Adventus Group Establishes Joint Venture for European Expansion with S&B Industrial Minerals
Adventus Group announced that it has signed an agreement for establishment of a joint venture (JV) with S&B Industrial Minerals. The agreement was signed between Adventus Intellectual Property Inc. (Canada based parent company of Adventus Americas Inc. and EnviroMetal Technologies Inc.), and S&B Industrial Minerals GmbH (Germany based affiliate of S&B Industrial Minerals S.A.). Established as Adventus Europe GmbH, the countries to benefit from this initiative include all EU member states as well as Switzerland, Norway, the Russian Federation and other markets in Eastern Europe.
The purpose of the newly formed company is to expedite market adoption of its patented and proprietary portfolio of applied environmental biotechnologies targeting the soil, sediment and groundwater remediation industry.
Implementation will be managed by Mr. Mike Mueller, Managing Director of Adventus Europe GmbH. He commented that “Our most important global distribution channel remains the environmental engineering and consulting community. This venture will be focused on helping a diverse and active geographical region address some of their most challenging client sites. Intra-EU manufacturing of our products, complimentary conceptual designs, collaborative risk sharing through performance guarantees, and quantifiable cost savings over competitive offerings are just a few of the differentiating customer benefits we will continue to provide our clients.”
Topics
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Analytik Jena AG establishes subsidiary in Thailand
Study suggests early exposure to antibiotics may impact development, obesity
Pharming's Ruconest(TM) for HAE granted European Marketing Authorization

Start-up receives €24 million for the development of a potential COVID-19 treatment - EIB backs Atriva Therapeutics
Access and SpePharm Announce Licensing of MuGard for Europe - SpePharm Will Market MuGard in Europe for the Treatment of Oral Mucositis
Sartorius Stedim Biotech and Bosch Packaging Technology Announce Global Collaboration
